| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1984 |
| Trial ID | NCT03690310 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD19 CAR-NK cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma |
| Year | 2019 |
| Country | China |
| Company sponsor | Allife Medical Science and Technology Co., Ltd. |
| Other ID(s) | CD19 CAR NK-BJZL-01 |
| Cohort 1 | |||||||||||
|
|||||||||||